Antiviral Medication Use
Thank you for participating in our brief survey. Look for the complete results to be published in the February 12 edition of UCAccess. For more information on the 2014-2015 flu season, view the results of UCAOA's brief survey on Influenza A (H3N2), which was published in the January 15 edition of UCAccess.

Survey Results: Antiviral Medication Use


Question:

Does your UC center prescribe the antiviral medications Tamiflu, Relenza and/or Rapivab?

  • A. Yes (11 out of 11)
  • B. No (0 out of 11)

Question:

If yes, does your UC center prescribe these medications for patients with unconfirmed flu-like symptoms?

  • A. Yes (5 out of 11)
  • B. No (3 out of 11)
  • C. Depends (3 out of 11)

Question:

Does your UC center perform rapid flu testing on all patients presenting with flu-like illness?
  • A. Yes (6 out of 11)
  • B. No (5 out of 11)

Question:

Do you consider antivirals (e.g. Tamiflu, Relenza, Rapivab) to be safe?
  • A. Yes (10 out of 11)
  • B. No (1 out of 11)

Question:

Please share your thoughts on this subject with us...

Membership Management Software Powered by YourMembership  ::  Legal